Cite Filings / IMRX / 0001790340-26-000020
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

Immuneering Corp · Filed 2026-01-22 · Acc 0001790340-26-000020

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2026-01-22 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-01-21 4 Chief Business Officer bought 5,250 shares at $4.76 ($24,990)
  • 2026-01-20 4 Director bought 21,645 shares at $4.67 ($101,041)
  • 2026-01-16 4 CHIEF SCIENTIFIC OFFICER bought 2,298 shares at $4.57 ($10,502)
  • 2026-01-15 4 CHIEF PEOPLE OFFICER bought 2,626 shares at $4.15 ($10,906)
  • 2026-01-15 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…